NAPROX EC tablets are indicated for the relief of the signs and symptoms of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and polyarticular juvenile idiopathic arthritis. This medicine is also indicated for the relief of signs and symptoms of tendonitis, bursitis and acute gout and for the management of pain and primary dysmenorrhea.
A pack contains 10 tablets
₵35.00
NAPROX EC tab 500mg – local blister
NAPROX EC tablets are indicated for:
the relief of the signs and symptoms of:
NAPROX EC tablets are also indicated for:
the relief of signs and symptoms of:
the management of:
ACTIVE INGREDIENTS
The active substance in Naprox EC 500 mg Tablets is naproxen 500mg
The other ingredients in the tablets are povidone, magnesium stearate, water, croscarmellose sodium, methacrylic acid – ethyl acrylate copolymer, purified talc, sodium hydroxide, triethyl citrate, iron oxide black, shellac and propylene glycol.
DOSAGE
Adults
Muscle, joint or tendon problems and period pain
Arthritis and ankylosing spondylitis
Older people and people with liver and kidney problems
Your doctor will decide your dose, it will usually be lower than that for other adults.
Use in children and adolescents
Naprox EC 500mg is not for use in children under 16 years of age.
SIDE EFFECTS
Serious stomach or gut problems, signs include: • Bleeding from the stomach, seen as vomit which has blood in it, or bits that look like coffee grounds.
Allergic reactions, signs include:
Severe skin rashes, signs include:
Heart attack, signs include:
WARNINGS AND PRECAUTIONS
Cardiovascular thrombotic events: avoid
Status post coronary / artery bypass graft (CABG) surgery
Post MI patients
Gastrointestinal bleeding, ulceration and perforations: avoid
Heart failure and edema
Hepatoxicity
Renal toxicity and hyperkalemia
Anaphylactic reactions
Serious skin reactions
Children and adolescents;
Naprox 500mg is not recommended for use in children under 16 years of age.
STORAGE
Do you have any questions? Do not hesitate to contact us.
Reviews
There are no reviews yet.